Full house at terraplasma, the innovation leader in the field of development and implementation of applications with cold plasma. Representatives of all participating partner companies of the joint research project “Disinfection of the exhaust air from ventilators with cold plasma (ventilation hygiene)”, which started on September 1st, met in the terraplasma premises in Garching near Munich. The first personal kick-off meeting took place under the motto “Action Anti-HAI – Innovations to combat hospital-associated infections”.
The campaign is about the development of medical technology solutions in the hospital environment, which are intended to prevent or reduce “Hospital-Associated Infections (HAI)”. With up to 600,000 infections and 20,000 deaths in Germany every year, these are not just a phenomenon of the various corona waves, but an ongoing issue. The increase in multi-resistant germs is particularly critical. According to a study by the AMR Industry Alliance, drug resistance deaths worldwide could increase to around 10 million per year in 2050.
HAIs are particularly prevalent in Intensive Care Units (ICUs) and 98% of HAIs in ICUs are associated with intubation. The spread of germs brought in by ventilation and suction devices is a critical point in the protection technology used to date. Germs are filtered, but not killed. The daily change and disposal of the ventilation filter therefore represents a permanent danger for the hospital staff and the patients.
The solution approach in the joint research project is the combination of proven filters with built-in plasma modules to inactivate bacteria and viruses directly in the exhaled air or in the suction area of the devices. The plasma treatment is based on highly efficient physical processes that prevent the formation of resistance. The planned development of a stable and cost-effective ceramic plasma electrode, together with a robust and reliable disinfection technology, will make a significant contribution to safety in hospitals and other healthcare facilities.
The joint research project of the Federal Ministry of Education and Research (BMBF) with the name “Disinfection of the exhaust air from ventilators with cold plasma (ventilation hygiene)” was approved on August 8, 2022 and the operational start took place on September 1, 2022 with a total duration of three years and a total volume of around €3 million. The project is being carried out together with partners from the Fraunhofer Society IKTS (Dresden) and the Fraunhofer Society IZI (Leipzig) and the companies QSIL Ceramics GmbH and Inmatec Technologies GmbH under the coordination of terraplasma GmbH.
We are very pleased that with Dorothee Jennrich, Dr. Michael Mei and Dr. Philipp Baaske were able to gain three top-class and experienced experts who will be available to advise us in the future.
As a small development company, we often have to make fundamental strategic decisions that have far-reaching consequences. Here, the advisory board is suitable as a discussion and discussion forum, because we from the management of terraplasma can exchange ideas with other entrepreneurially thinking, scientifically educated and market-experienced personalities.
“As a small-sized company, we cannot have personnel-intensive staff or business areas like large corporations,” says our CEO Dr. Julia Zimmerman. “As a counterbalance, our new advisory board can bring valuable expertise to various aspects of our corporate governance, such as expertise in the areas of business development and business strategy. With this additional help, we can then make even more informed and faster decisions.”
With its external advice, the Advisory Board can also prevent a certain “operational blindness”, point out new ways and thus reduce the risk of wrong decisions. In addition, an advisory board “forces” us in a positive sense that we have to justify our ideas in front of others, which promotes successful concepts overall.
We are looking forward to working with Dorothee, Michael and Phillip 😊
The BMBF (Federal Ministry of Education and Research) joint research project „disinfection of ventilation exhaust air of respirators with cold plasma (respiration hygiene)” was approved on the 8th of August 2022 and is started at the 1st of September 2022. The project will be supported for 3 years by the BMBF with the support code 13GW0599A. The cooperation is a concerted effort of the terraplasma GmbH, partners of the Fraunhofer society (IKTS, Dresden and IZI, Leipzig), as well as the companies QSIL Ceramics GmbH and Inmatec Technoligies GmbH. The project is coordinated by the terraplasma GmbH and has a financial volume of about 3 Mio. €.
„Hospital Associated Infections (HAI)“ are not only a corona phenomenon, claiming 600.000 infections and 20.000 deaths in Germany each year. Especially critical in that context is the increase of multi-resistant germs. According to a study of the AMR industry alliance, deaths caused by drug resistance in germs could rise to 10 Mio. per year worldwide in the year 2050.
HAI appear preferentially in intensive care units (ICUs) where 98 % of HAI are associated with intubation. The spread of germs introduced by respirators and aspirators is a critical point in the currently used protection technology. Presently, germs are filtered but not inactivated. Therefore, the daily change and disposal of filters poses a permanent threat to patients and hospital personnel.
The approach of our project to a solution of the problem is the combination of filters with built-in plasma modules. The plasma modules inactivate bacteria and viruses directly in the breathing air and the suction area of the devices respectively. The plasma treatment is based on highly efficient physical processes, which avoid resistance formation amongst pathogens.
The development of a stable and cost-effective ceramic plasma electrode, together with a robust and reliable disinfection technique, will significantly contribute to the safety in hospitals and other healthcare facilities.
Join terraplasma at ICPM9
June 21, 2022
Are you interested in the applications of plasma? Join the terraplasma team on the 9th international conference on plasma medicine (ICPM) to discover the wonders and latest breakthroughs with cold plasma. We will be waiting for you at our stand from 27th – 30st of June. Stop by for insights about our research and products!
In the interview, Julia talks about her experience of founding terraplasma, gives insights about the day-to-day business, and shares a piece of advice. Click here, don’t miss it! (3 min reading).
Space technology for the mass market
April 26, 2022
Our new product „Happy Plasma Teeth“ for gentle teeth whitening with PAW is now supported by ESA Spark Funding. In this project we use space technology in applications for the end-consumer to create a revolutionary experience.
Patent granted in Europe
January 26, 2022
Our patent application “Plasma Activated Water” has been granted in Europe (EP3411085). The patent covers the production of plasma-activated water for the disinfection of objects, especially dentures and/or the treatment of teeth.
Typically, chemical solutions are used for cleaning dentures, especially outside the mouth, but they contain comparatively high concentrations of cleaning chemicals. However, the problem is that these solutions are not suitable for consumption – as is the case with toothpaste, which at best should not be swallowed. Furthermore, for the bleaching of dentures and/or teeth, concentrations of hydrogen peroxide are usually used that are far above the EU limit for non-professional tooth bleaching.
Here, plasma activated water offers a safe, waste-free alternative.
The patent protection should further strengthen terraplasma´s competitive position in the plasma field.
Acquisition of terraplasma medical GmbH by the Viromed Group
December 11, 2021
Today the majority takeover of terraplasma medical GmbH by Viromed Plasma GmbH, a company of the Viromed Group, was announced. terraplasma GmbH will continue to be involved in terraplasma medical GmbH as a partner in order to contribute its expertise in the field of cold atmospheric plasmas in the future.
Wound treatment with cold plasma – plasma care® takes Max Planck Institute research to the hospitals
July 22, 2021
New hope for patients with open wounds: plasma care® medical products from terraplasma medical GmbH can inactivate fungi and bacteria and even multi resistant organisms. Healthy tissue is not damaged in this process. Prof. Dr. Dr. h.c. Gregor Morfill (CTO terraplasma GmbH), former director of the Max Planck Institute for Extraterrestrial Physics and Senior Scientific Advisor at terraplasma- medical GmbH has developed this technology based on profound research in space. The mobile, battery-operated device is about the size and weight of a travel hair dryer. plasma care® can be used in clinical and private settings as well as in outpatient care services and wound care providers. From June 1st 2021, the plasma care® device will be distributed exclusively by Viromed GmbH in Germany, Austria and Switzerland and can be used for millions of patients. Apart from the bactericidal and wound healing effect, the health care system also benefits from decisive economic advantages. Currently these are: Reduction of health care costs, shortened hospitalization time and improved quality of life for patients.
Business delegation from the UAE learns about the use of plasma technology at the terraplasma group in Garching
July 12, 2021
Cold atmospheric plasma is a promising technology for the inactivation of germs and bacteria. The possibilities of cold plasma application as well as its implementation in different areas of life, led a delegation of the UAE to terraplasma GmbH and terraplasma medical GmbH to Munich. H.E. Mariam Al Mheiri, Minister of Agriculture of the UAE, H.E. Hafsa al Ulama, Ambassador in Berlin and two other members of the delegation were informed by Dr. Julia Zimmermann (CEO terraplasma GmbH) and Jens Kirsch (CEO terraplasma medical GmbH) about the application possibilities of cold atmospheric plasma and received a demonstration. For instance, in Europe its use in wound care is already well established. The representatives were particularly interested in the use of cold atmospheric plasma for water purification in agriculture, the decontamination of fruit and vegetables as well as the application in the health sector. “We were very pleased about the great interest and look positively forward to a long-term cooperation with the UAE Ministry of Agriculture,” says CEO Dr Julia Zimmermann. A visit with further decision-makers is already being planned.
BOSCH FreshUp – Textile refreshment at home or on the go with plasma technology licensed from terraplasma
June 21, 2021
We are very pleased to announce that the BOSCH FreshUp for textile refreshment with the plasma technology licensed by terraplasma is now hitting the market in the UK.
On the occasion of terraplasma’s 10th anniversary we would like to thank our employees, customers and cooperation partners for the successful past years!
New Managing Director at terraplasma
May 05, 2021
As of 1 May 2021, we are pleased to announce a personnel change in the management of terraplasma. After 10 years of managing and founding the company, Prof. Dr. Dr. Gregor Morfill is stepping down as Managing Director of terraplasma GmbH. He will continue pursuing his key role in the company as Chief Scientific Officer.
Mr Rico Unger has been appointed new Managing Director. After studying electrical engineering / medical technology he has already been working successfully as a developer, manager and managing director in the medical technology industry for more than 15 years. His many years of experience in research & development and in particular his ability to combine technical areas in order to turn an idea into a product has already been used effectively in the past.
Thus, terraplasma is now headed by the joint management of PD Dr. Julia Zimmermann (CEO) and Rico Unger (CTO).
Patent granted in China
March 17, 2021
On 05.11.2019 the United States Patent Office granted our patent application (US 10,470,285 B2) with the title
„Electrode Assembly and Plasma Source for Generating a Non-Thermal plasma and Method for Operating a Plasma Source”
The patent has now also been granted in China (ZL 2016800431550). A decision in Japan and Europe is imminent. This patent concerns a “thin film electrode” for the production of a cold atmospheric plasma at low voltages, which is suitable for mass production at low cost. This electrode is an important element in our terraplasma development of miniaturized plasma sources for the treatment of skin diseases, for aiding wound healing, for combating viral, fungal and bacterial infections, for inactivating odours, harmful molecules and allergens, for air and water purification and many other applications in medicine and hygiene.
The patent protection should further strengthen terraplasma´s competitive position in the plasma field.
Funding received for our development project “Little Plasma”
November 02, 2020
We are very pleased to announce that our proprietary development “Little Plasma” for the disinfection of everyday utensils (such as FFP2 masks, car or door keys, glasses, cell phones etc.) with cold atmospheric plasma is now supported by the program for research, development and innovation of the Bavarian Ministry of Economic Affairs “Bayern Innovativ” (Baytp).
terraplasma is relocating
December 04, 2019
In December 2019 we will move into our new offices, located at the Business Campus Garching.
Therefore, we will be partly offline from December 11th to 17th, 2019. Thank you for your understanding.
Our new address: Parkring 32 85748 Garching
terraplasma at MEDICA 2019
November 12, 2019
On Monday, November 18, 2019, Ms. Dr. Julia Zimmermann (CEO) and Ms. Sylvia Cantzler (Project Manager) will be at MEDICA in Düsseldorf to inform themselves about new applications in the field of medical technology with cold atmospheric plasma and to seek contact with potential cooperation partners.
If you attend the fair at the same day and are interested in a personal meeting, please contact Ms. Dr. Zimmermann (+49 89 9545 769-12).
We are looking forward to interesting impressions and conversations!
Sylvia Cantzler presented cold atmospheric plasma at the CEMS-ESA seminar in the Netherlands
August 30, 2019
For the 15th time, international CEMS master students from the Rotterdam School of Management (RSM) gathered at the ESTEC Space Technology Center of the European Space Agency (ESA) in order to find business opportunities on earth based on a space-technology and to develop business concepts out of it.
As part of the event, Sylvia Cantzler was invited to introduce cold atmospheric plasma as well as the terraplasma technologies and current applications. Students on the other hand were asked to develop business cases for potential cold plasma products and applications based on their then newly acquired knowledge.
The CEMS-ESA workshop has been a great opportunity for terraplasma to identify the potential for further developments and the chance to brainstorm outside the box.
We would like to thank Mr Niels Eldering, representing ESA, for the invitation and Mr Bas Jan Veldhoen, for bringing the students and Sylvia Cantzler together and who continuously motivated, supported and encouraged everyone to find unique ideas.
We would also like to thank all the students for their creative and clever ideas, their qualified development and extremely pleasant cooperation. Exciting and convincing business plans have been created!
DLR (German Aerospace Center) project for plasma-activated water granted
August 14, 2019
terraplasma receives funding for the project to extend the shelf life of fruit and vegetables with plasma-activated water
terraplasma’s application “Plasma-activated water (PAW) for the extension of the shelf life of fruit and vegetables” has been granted with a six-digit EUR amount by the German Aerospace Center (Zentrum für Luft- und Raumfahrt e.V.) and the Federal Ministry for Economic Affairs and Energy.
The aim of this project is the development of a functional model for the production of “plasma-activated water” (PAW) in order to reduce bacteria and fungi on fruit and vegetables. The so-called thin-film technology – a further development of the surface micro-discharge technology – is to be used for this purpose, which uses ambient air and energy to generate a cold atmospheric plasma by means of micro-discharges. This reduces the bacterial and fungal load on fruit and vegetables. Consequently, the potential risk of infection for humans is decreased and the shelf life of these products can be prolonged without changing the vitamin or nutrient content.
August 05, 2019
We gladly announce that the grant of our patent application “Electrode assembly and plasma source for generating a non-thermal plasma, and method for operating a plasma source” was promised in the United States.
An overview of our own patents and patent applications as well as patents with license agreements can be found here.
terraplasma receives funding for the project “Air Treatment with Cold Atmospheric Plasma”
July 29, 2019
terraplasma GmbH obtains a six-digit EUR grant for the project “Air Treatment with Cold Atmospheric Plasma” from the funding program “Central Innovation Program for SMEs” (ZIM) of the Federal Ministry for Economic Affairs and Energy (BMWi).
The aim of this project is the development of an air purification module for cleaning the room air using cold atmospheric plasma.
terraplasma ideation workshop
July 26, 2019
terraplasma’s first ideation workshop took place from 24 to 25 July 2019. The aim of this workshop was to use the idea potential of our employees, external partners and shareholders in order to generate new ideas for cold plasma applications. With a joint brainstorming as well as idea sorting and prioritization, 8 ideas for new applications were selected, which were elaborated in group work and presented afterwards. In the course of this workshop, interesting projects were presented, which are now to be exploited within our company.
Dr. Julia Zimmermann @ Hello Tomorrow Global Summit 2019
January 11, 2019
We gladly announce that Dr. Julia Zimmermann is one of the speakers at the Hello Tomorrow Global Summit on March 14 and 15, 2019. In her keynote “Cold Plasma – From Space Research to Earth Medicine” she will talk about how newly developed plasma-based therapies, which first were researched at the ISS, can keep patients safe from infections and treat chronic wounds without damaging tissues.
terraplasma receives funding for the “plasma refresher”
December 11, 2017
The application “Removal of odours from textiles using cold plasma” from terraplasma GmbH was granted with a six-digit EUR amount by the “Central Innovation Programme for SMEs” of the Federal Ministry of Economic Affairs and Energy.
Within this project a small, mobile end consumer device, the so-called “plasma refresher”, is developed. The “plasma refresher” incorporates a coated plasma source for the generation of cold atmospheric plasma to permanently eliminate odours from textiles within seconds.
It is planned to distribute the “plasma refresher” to private users via license partners.
terraplasma won the pitch competition from Mentimeter
July 07, 2017
terraplasma rocks! terraplasma won against 11 competitors in all categories of the pitch competition from Mentimeter at the ESA event “R(e)volution in Space – Exploring Your New Business” (3.-4. July 2017):
On the occasion of terraplasma’s 5th anniversary we would like to thank our employees, customers and cooperation partners for the successful past years!
Wound treatment with medicative plasma
April 15, 2016
In April 2016, an interesting article about cold atmospheric plasmas and their application in the field of wound treatment was published in the new edition of the Physik Journal. This article was supported by helpful explanations of PD Dr. Julia Zimmermann. Read the article here.
Bayerischer Rundfunk (BR): “plasma in medical science”
April 13, 2016
On April 6, 2016 the local radio station Bayerischer Rundfunk (BR) broadcasted an interview with our CEO PD Dr. Julia Zimmermann regarding the topic “plasma in medical science”. Please access the report here.